Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death
Tóm tắt
Immunogenic cell death (ICD)-associated immunogenicity can be evoked through reactive oxygen species (ROS) produced via endoplasmic reticulum (ER) stress. In this study, we generate a double ER-targeting strategy to realize photodynamic therapy (PDT) photothermal therapy (PTT) immunotherapy. This nanosystem consists of ER-targeting pardaxin (FAL) peptides modified-, indocyanine green (ICG) conjugated- hollow gold nanospheres (FAL-ICG-HAuNS), together with an oxygen-delivering hemoglobin (Hb) liposome (FAL-Hb lipo), designed to reverse hypoxia. Compared with non-targeting nanosystems, the ER-targeting naosystem induces robust ER stress and calreticulin (CRT) exposure on the cell surface under near-infrared (NIR) light irradiation. CRT, a marker for ICD, acts as an ‘eat me’ signal to stimulate the antigen presenting function of dendritic cells. As a result, a series of immunological responses are activated, including CD8+ T cell proliferation and cytotoxic cytokine secretion. In conclusion, ER-targeting PDT-PTT promoted ICD-associated immunotherapy through direct ROS-based ER stress and exhibited enhanced anti-tumour efficacy.
Từ khóa
Tài liệu tham khảo
Holzel, M., Bovier, A. & Tuting, T. Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? Nat. Rev. Cancer 13, 365–376 (2013).
Begley, J. & Ribas, A. Targeted therapies to improve tumor immunotherapy. Clin. Cancer Res. 14, 4385–4391 (2008).
Garg, A. D. et al. Trial watch: immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology 6, e1386829 (2017).
Apetoh, L. et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13, 1050–1059 (2007).
Radogna, F. & Diederich, M. Stress-induced cellular responses in immunogenic cell death: implications for cancer immunotherapy. Biochem. Pharmacol. 153, 12–23 (2018).
Garg, A. D., Dudek-Peric, A. M., Romano, E. & Agostinis, P. Immunogenic cell death. Int. J. Dev. Biol. 59, 131–140 (2015).
Garg, A. D. et al. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim. Biophys. Acta 1805, 53–71 (2010).
Spang, A. The endoplasmic reticulum-the caring mother of the cell. Curr. Opin. Cell Biol. 53, 92–96 (2018).
Garg, A. D. & Agostinis, P. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses. Photochem. Photobiol. Sci. 13, 474–487 (2014).
Kepp, O. et al. Crosstalk between ER stress and immunogenic cell death. Cytokine Growth Factor Rev. 24, 311–318 (2013).
Verfaillie, T., Garg, A. D. & Agostinis, P. Targeting ER stress induced apoptosis and inflammation in cancer. Cancer Lett. 332, 249–264 (2013).
Garg, A. D. et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 31, 1062–1079 (2012).
Adkins, I., Fucikova, J., Garg, A. D., Agostinis, P. & Špíšek, R. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. OncoImmunology 3, e968434 (2014).
Abels, C. et al. Indocyanine green (ICG) and laser irradiation induce photooxidation. Arch. Dermatol. Res. 292, 404–411 (2000).
Cheng, Y. et al. Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. Nat. Commun. 6, 8785–8793 (2015).
Dang, J., He, H., Chen, D. & Yin, L. Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT). Biomater. Sci. 5, 1500–1511 (2017).
Jia, Y., Duan, L. & Li, J. Hemoglobin-based nanoarchitectonic assemblies as oxygen carriers. Adv. Mater. 28, 1312–1318 (2016).
Sakai, H., Sou, K., Horinouchi, H., Kobayashi, K. & Tsuchida, E. Review of hemoglobin-vesicles as artificial oxygen carriers. Artif. Organs 33, 139–145 (2009).
Obeid, M. et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54–61 (2007).
Garg, A. D. et al. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy 9, 1292–1307 (2013).
Panaretakis, T. et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J. 28, 578–590 (2009).
Sano, R. & Reed, J. C. ER stress-induced cell death mechanisms. Biochim. Biophys. Acta 1833, 3460–3470 (2013).
Li, Y., Guo, Y., Tang, J., Jiang, J. & Chen, Z. New insights into the roles of CHOP-induced apoptosis in ER stress. Acta Biochim. Biophys. Sin. (Shanghai) 46, 629–640 (2014).
Zhao, B., Li, X., He, R., Cheng, S. & Juan, X. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys. 14, 175–185 (1989).
Gardai, S. J. et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321–334 (2005).
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97–111 (2016).
Mbongue, J. C., Nieves, H. A., Torrez, T. W. & Langridge, W. H. The role of dendritic cell maturation in the induction of insulin-dependent diabetes mellitus. Front. Immunol. 8, 327–336 (2017).
Leone, D. A., Rees, A. J. & Kain, R. Dendritic cells and routing cargo into exosomes. Immunol. Cell Biol. 7, 683–693 (2018).
Speiser, D. E., Ho, P. C. & Verdeil, G. Regulatory circuits of T cell function in cancer. Nat. Rev. Immunol. 16, 599–611 (2016).
Dudek, A. M., Martin, Garg, A. D. & Agostinis, P. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front. Immunol. 438, 1–14 (2013).
Garg, A. D., Dudek, A. M. & Agostinis, P. Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity. OncoImmunology 2, e26260 (2013).
Panzarini, E., Inguscio, V. & Dini, L. Immunogenic cell death: can it be exploited in photodynamic therapy for cancer? Biomed. Res. Int. 2013, 482160–482178 (2013).
Palombo, F., Focaccetti, C. & Barnaba, V. Therapeutic implications of immunogenic cell death in human cancer. Front. Immunol. 4, 503–509 (2014).
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. & Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56, 185–229 (2004).
Krysko, D. V. et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860–875 (2012).
Hou, X. et al. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment. Int. J. Cancer 143, 3050–3060 (2018).
You, J. et al. Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors. Cancer Res. 72, 4777–4786 (2012).
Li, W. et al. Gold nanospheres-stabilized indocyanine green as a synchronous photodynamic−photothermal therapy platform that inhibits tumor growth and metastasis. ACS Appl. Mater. Interfaces 9, 3354–3367 (2017).
Pinton, P., Giorgi, C., Siviero, R., Zecchini, E. & Rizzuto, R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 27, 6407–6418 (2008).
Grimm, S. The ER–mitochondria interface: The social network of cell death. Biochim. Biophys. Acta 1823, 327–334 (2012).
Mahjub, R. et al. Recent advances in applying nanotechnologies for cancer immunotherapy. J. Control. Release 288, 239–263 (2018).
Yang, Y. et al. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner. PLoS ONE 7, e50811 (2012).